AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 274: F635-F641, 1998;
0363-6127/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ying, W.-Z.
Right arrow Articles by Sanders, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ying, W.-Z.
Right arrow Articles by Sanders, P. W.
Vol. 274, Issue 4, F635-F641, April 1998

Dietary salt modulates renal production of transforming growth factor-beta in rats

Wei-Zhong Ying and Paul W. Sanders

Nephrology Research and Training Center, Comprehensive Cancer Center, and Cell Adhesion and Matrix Research Center, Division of Nephrology, Department of Medicine and Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham 35294-0007; and Department of Veterans Affairs Medical Center, Birmingham, Alabama 35233

    ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

Transforming growth factors (TGF) are potent multifunctional polypeptides that are involved in renal function and glomerular sclerosis. We postulated that dietary salt modified renal production of TGF-beta . An increase in dietary salt produced sustained increases in steady-state levels of mRNA for TGF-beta 1, -beta 2, and -beta 3 in the rat kidney. While serum concentration of TGF-beta 1 did not change, the 8.0% NaCl diet increased urinary excretion of TGF-beta 1, indicating enhanced renal production was the source of TGF-beta 1. Increasing urinary flow rates with diuretics did not further increase synthesis of TGF-beta 1 in animals receiving the 8.0% NaCl diet. The 8.0% NaCl diet increased production of TGF-beta 1 in both glomeruli and tubules, although active TGF-beta 1 was secreted in greater amounts only from glomeruli. Enhanced glomerular production of both inactive and active TGF-beta 1 induced by the 8.0% NaCl diet was inhibited by tetraethylammonium (TEA) and not glybenclamide. Cardiac production of TGF-beta 1 also increased on the 8.0% NaCl diet but was not affected by TEA. The results demonstrated that increased dietary salt augmented glomerular TGF-beta production by a mechanism that included a TEA-sensitive potassium channel. Dietary salt, by facilitating glomerular expression of TGF-beta , may directly promote development of glomerulosclerosis.

glomerulus; potassium channel; sodium chloride

    INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

TRANSFORMING GROWTH FACTOR (TGF) was a term used initially by Roberts and associates (38) in 1980 to describe a collection of polypeptides that could be extracted from almost any normal tissue of the mouse. These peptides were functionally divided into TGF-alpha , which competed with epidermal growth factor (EGF) for receptor binding and did not require EGF to promote growth of normal rat kidney (NRK) cells in culture, and TGF-beta , which did not compete with EGF for receptor binding but did require EGF to stimulate growth (7). TGF-beta s are now known as a family of five multifunctional polypeptides that have complex effects on organ development, cell growth, and differentiation, expression of extracellular matrix proteins, immune responses, angiogenesis, and tissue repair, as reviewed in detail by Roberts and Sporn (39). Mammals produce TGF-beta 1, -beta 2, and -beta 3 but not -beta 4 or -beta 5. The biological effects, which are similar among the TGF-beta s, depend upon the target cell, the degree of cellular differentiation, and the cellular environment (37). TGF-beta s are synthesized in latent form and secreted as disulfide-linked homodimers of ~100 kDa. Removal of the amino terminus of latent TGF-beta in the extracellular space forms a mature, biologically active form of TGF-beta that has a molecular weight of ~25 kDa (39). How this latent TGF-beta complex is activated in vivo is unclear, although acidification, protease treatment, and interaction with thrombospondin have also been shown to activate TGF-beta in vitro (8, 39, 42-44). The complex structure and function of the kidney make it a prime target for the action of a growth factor. TGF-beta 1 is present in glomeruli and all nephron segments of normal rat kidney (6).

It is well accepted that angiotensin II modulates TGF-beta (3, 20, 25, 28, 49). In apparent contradiction of these findings, however, was the recent report (47) that demonstrated enhanced glomerular expression of TGF-beta in the Brookhaven strain of salt-sensitive rats, which have a low-renin form of hypertension. Conclusions about the direct role of dietary salt were not entertained in that study, because, at the time of examination, the animals had severe hypertension and renal damage, which provided additional modifying variables. In addition, time-course experiments were omitted, and normotensive strains that did not have renal failure were not included. We hypothesized that dietary salt directly modulated expression of TGF-beta through a mechanism independent of the renin-angiotensin system. Using immunoassay and Northern hybridization analysis, we document in the present study the effect of dietary salt on the renal expression of TGF-beta in Sprague-Dawley rats.

    METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Animal preparation. Studies were conducted on 56 male Sprague-Dawley rats obtained at 28 days of age from Charles River Laboratories (Wilmington, MA). Animals were chosen at this age because of our previous experience that showed normal renal function and blood pressure responses to dietary salt over 2 wk of observation (13). The rats were housed under standard conditions and given 0.3% NaCl diet (AIN-76A with 0.3% NaCl; Dyets, Bethlehem, PA) and water ad libitum for 4 days before initiating the experiment. This diet contained sodium chloride in amounts similar to standard rat diet. The animals were then placed in metabolic cages and allowed free access to water and rat diet, which contained either 0.3% (group termed Lo-salt) or 8.0% (AIN-76A with 8.0% NaCl, Dyets) (group termed Hi-salt) sodium chloride (n = 24 for each group). Animals received salt only in the diet. Urine was collected under oil to prevent desiccation. Urine volume and body weight were recorded daily. In other experiments, rats on 8.0% NaCl diet received twice daily intraperitoneal injections of either furosemide (5 mg/kg, denoted Hi-F; Elkins-Sinn, Cherry Hill, NJ) or chlorothiazide (4 mg/kg, denoted Hi-C; Merck, West Point, PA) (n = 4 in each group). Collected urine samples from each rat were filtered and centrifuged at 325 g for 5 min at 4°C. The supernatant was collected and immediately frozen and stored at -80°C until use. Rats were killed on days 1, 4, and 15. Both kidneys were harvested under aseptic conditions for glomerular and tubular cell culture and Northern hybridization analysis, as described below. Blood was collected simultaneously for determination of serum TGF-beta 1 and sodium concentration. Plasma and urine samples were analyzed for sodium and potassium using flame photometry (model IL-943; Instrumentation Laboratories, Lexington, MA).

Glomerular and tubular cell culture. Glomerular and tubular cell preparations were isolated using a graded sieving technique. This protocol has been shown to produce pure and viable glomeruli for study of TGF-beta (11, 27, 47, 48). Rats were anesthetized with pentobarbital, 50 mg/kg, by intraperitoneal injection. The kidneys were perfused in situ via the aorta with cold isotonic heparinized saline until blanched (50-60 ml saline over 2 min). The renal cortices from each rat were individually dissected and minced to a pastelike consistency. The homogenate was passed successively through a 106-µm metal sieve that excluded blood vessels and a 75-µm nylon sieve that retained the glomeruli and allowed cells and small tubular segments to pass through. Glomeruli and tubules were collected separately and washed three times with ice-cold PBS at 120 g for 2 min, then resuspended at 5 × 103 glomeruli or 1 × 106 tubular cells/ml of serum-free RPMI 1640 (GIBCO; Life Technologies, Grand Island, NY). All glomerular preparations consisted of more than 95% glomeruli with minimal tubular contamination, as assessed visually at ×40 magnification. Some freshly collected samples of glomeruli were used to obtain total RNA, as described below. In other experiments, samples of glomeruli and tubules in 24-well plates were pretreated with tetraethylammonium chloride (TEA, 3 mM; Sigma, St. Louis, MO) or glybenclamide (10-5 M, Sigma), in serum-free RPMI media at 37°C. Glybenclamide was dissolved in DMSO; final concentration of DMSO in the medium was 0.002%. TEA in this dose specifically inhibits potassium channels but is relatively nonselective, whereas glybenclamide inhibits KATP channels (12, 15, 16, 34, 35); both compounds have been used specifically to examine TGF-beta production by endothelial cells (34). Following a 30-min incubation period, the medium was removed and replaced with serum-free media that contained the same concentrations of TEA and glybenclamide. All samples were then incubated for 24 h at 37°C. In these same animals, the heart was also dissected and sectioned. Coronal slices of heart tissue were weighed in a petri dish, then minced with a scalpel into small pieces <1 mm in diameter. The sections were rinsed with cold PBS and suspended in serum-free RPMI 1640 at a concentration of 10 mg tissue/ml. After incubation for 24 h, samples of conditioned media were harvested. Phenylmethylsulfonyl fluoride (1 mM, Sigma) was added as a protease inhibitor, and the mixture was centrifuged at 200 g for 5 min at 4°C. The pellet was dissolved in RIPA buffer (50 mM Tris hydrochloride, 150 mM NaCl, 1 mM disodium EDTA, 0.1 mM EGTA, 1.0% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate) for protein assay (Micro BCA protein assay reagent kit; Pierce, Rockford, IL), and the supernatant was collected and stored at -20°C until assay.

TGF-beta 1 assay. Total TGF-beta 1 in rat urine, serum, and conditioned media was determined using an enzyme immunoassay (TGF-beta 1 Emax ImmunoAssay System; Promega, Madison, WI), following the protocol provided by the manufacturer. Briefly, plates containing 96 flat-bottom wells (Falcon; Becton-Dickinson, Oxnard, CA) were coated overnight at 4°C with 100 µl of anti-TGF-beta 1 monoclonal antibody diluted 1:1,000 in buffer that contained 0.025 M sodium bicarbonate and 0.025 M sodium carbonate, pH 9.7. Thereafter, unbound sites in the wells were blocked, using 270 µl of the blocking reagent supplied in the kit for 2 h at room temperature, then 100 µl of the test samples or TGF-beta 1 standard diluted in sample buffer was added to wells. Following incubation for 3 h at room temperature with vigorous shaking, the wells were washed five times with TBST wash buffer (20 mM Tris · HCl, pH 7.6, 150 mM NaCl, and 0.05% Tween-20), then 100 µl of polyclonal anti-TGF-beta 1 diluted in sample buffer was added. The plates were again incubated overnight at 4°C. After five washes with TBST buffer, wells were filled with 100 µl of antibody conjugated with horseradish peroxidase and incubated for 3 h at room temperature with shaking. Following additional washes as in the previous steps, color was developed by adding 100 µl of peroxidase substrate in 3,3',S,S'-tetramethyl benzidine solution. After ~10-min incubation at room temperature, 100 µl of 1 M phosphoric acid were added to stop the color reaction. Optical density was determined at 450 nm using a microplate reader (THERMOmax; Molecular Devices, Menlo Park, CA). Standards were performed in duplicate using TGF-beta 1, 7.8-1,000 pg/ml in sample buffer, and were used to construct standard curves from which the concentrations of the samples were determined. Urine samples from animals on the 0.3% NaCl diet were diluted 1:1 in sample buffer, and urine samples from animals on 8.0% NaCl diet were not diluted. Serum samples were diluted 1:50 in sample buffer for this assay. Because this assay detected only active TGF-beta 1, some samples of media were also acidified to convert latent TGF-beta 1 to the active from. This protocol was provided by the manufacturer and briefly consisted of acidifying 100 µl of sample to pH 3.2 by addition of 2 µl of 1 N HCl for 30 min at room temperature. The transiently acidified samples were then brought to pH 7.4 with 2 µl of 1 N NaOH. Assay then proceeded as described above and allowed determination of total (latent plus active) TGF-beta 1 in the sample.

Northern hybridization. Total RNA was isolated by single-step method of acid guanidinium thiocyanate-phenol chloroform extraction (14). Briefly, kidneys were homogenized in a denaturing solution of 4 M guanidinium isothiocyanate, 0.5% sarcosyl, and 0.1 M beta -mercaptoethanol in 25 mM sodium citrate (pH 7.0). After phenol/chloroform extraction, the RNA was precipitated twice with isopropanol and washed with 70% ethanol. The concentration and purity of RNA in each sample were determined using optical density at 260 and 280 nm. Thirty micrograms of total RNA from each sample were electrophoresed in 1.5% agarose gels containing 2.2 M formaldehyde and 0.2 M MOPS, pH 7.0, then transferred to a nylon membrane (GeneScreen Plus Hybridization Transfer Membrane; NEN Life Science Products, Boston, MA) by vacuum blotting (model 785; Bio-Rad, Hercules, CA) for 2 h in 10× SSC (1× SSC is 0.15 M NaCl and 0.015 M sodium citrate, pH 7.0). Nucleic acids were cross-linked by ultraviolet irradiation (Stratagene, La Jolla, CA). The membranes were prehybridized for 20 min at 68°C in standard hybridization solution (QuikHyb; Stratagene). They were then hybridized at 68°C for 4 h with cDNA probes for rat TGF-beta 1 and murine TGF-beta 2 and TGF-beta 3 (all kindly provided by Dr. Thomas S. Winokur, University of Alabama at Birmingham). The cDNA probes, which consisted of ~1-kb fragments produced by digestion of the plasmids with Hind III and Xba I and included the entire coding region of the TGF-beta s (19), were labeled with [alpha -32P]dCTP by random oligonucleotide priming (Prime-a-Gene Labeling system; Promega). The blots were washed in 2× SSC with 0.1% SDS at room temperature for 30 min and in 0.1× SSC with 0.1% SDS at 60°C for 20-30 min. Membranes were exposed to XAR-5 film (Kodak) at -80°C. The blots were then stripped in solution containing 1 mM Tris · HCl, pH 8.0, 0.1 mM EDTA, and 0.1× Denhardt's solution, at 75°C for 2 h and rehybridized with human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe obtained through American Type Culture Collection (Rockville, MD). Autoradiographs were scanned using a densitometry (model 620 Video Densitometer, Bio-Rad). The density of the GAPDH band in the same lane was used to normalize mRNA loading. For quantification, densities of the bands of TGF-beta s were individually divided by the density of band for GAPDH in the same lane.

Statistical analysis. All data are presented as means ± SE. Significant difference among data sets was determined using either unpaired t-test or one-way analysis of variance with standard post hoc testing (Statview, version 4.5; Abacus Concepts, Berkeley, CA), where appropriate. Simple regression (Statview) was used to determine the relationship between dependent and independent variables. A value of 5% was used to assign statistical significance.

    RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Mean body weights, serum Na+ concentration, urinary flow rate, urinary sodium excretion rate, and urinary potassium excretion rate are shown in Table 1. One animal in the Lo-salt group died of unexplained causes. As expected, urinary flow rate and urinary sodium and potassium excretion rates of the Lo-salt groups were less (P < 0.05) than the corresponding Hi-salt groups. Mean body weight of the Lo-salt group on the diet for 4 days was less (P < 0.05) than the corresponding Hi-salt group.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Compiled data of the groups of animals in the study

Mean serum concentrations of TGF-beta 1 did not change during salt loading or with addition of furosemide or chlorothiazide (Tables 2 and 3). In marked contrast, urinary excretion of total TGF-beta 1 was much higher than in rats on the 8.0% NaCl diet. The effect of dietary salt occurred by the first day and persisted throughout the 15 days of study. Urinary excretion of TGF-beta 1 correlated (r2 = 0.561; P < 0.0001) directly with urinary sodium excretion rates. Both of the diuretics increased urinary flow but did not produce further increases in excretion of TGF-beta 1. In these experiments, urinary excretion of TGF-beta 1 did not correlate with urine flow rate (r2 = 0.052; P = 0.3356).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Effect of dietary salt on relative steady-state levels of mRNA of TGF-beta 1, -beta 2, and -beta 3 and serum levels and urinary excretion of TGF-beta 1

Mean steady-state levels of mRNA of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the kidney were also greater (P < 0.05) than mRNA levels of these growth factors in animals on 0.3% NaCl diet (Figs. 1 and 2; Tables 2 and 3). Steady-state levels of mRNA correlated (r2 = 0.374; P < 0.0001) directly with urinary excretion of total TGF-beta 1. Freshly isolated glomeruli from rats receiving the 8.0% NaCl diet for 4 days also had a higher content of TGF-beta 1 mRNA than rats receiving the 0.3% NaCl diet (Fig. 3). Furosemide produced further increases (P < 0.05) in mRNA of TGF-beta 3, but not TGF-beta 1 or TGF-beta 2, compared with animals on the 8.0% NaCl diet alone (Table 3).


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 1.   Northern hybridization study demonstrating the effect of dietary salt on steady-state levels of transforming growth factor (TGF)-beta 1, -beta 2, and -beta 3. An increase in dietary salt produced sustained increases in these growth factors over the 15 days of study. Samples were electrophoresed together on the same gels. Quantified results are in Table 2. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 2.   Northern hybridization analysis of effects of addition of twice daily intraperitoneal injections of furosemide (Hi-F, 5 mg/kg/day) or chlorothiazide (Hi-C, 4 mg/kg/day) to the 8.0% NaCl diet. Samples were electrophoresed together on the same gels. Quantified results are in Table 3.

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Effect of CLZ and furosemide on relative steady-state levels of mRNA of TGF-beta 1, -beta 2, and -beta 3 and serum levels and urinary excretion of TGF-beta 1


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 3.   Total RNA was obtained from freshly isolated glomeruli from rats on 0.3% NaCl (Lo-salt) and 8.0% NaCl (Hi-salt) diets for 4 days (n = 4 rats in each group). Northern analysis demonstrated a greater relative amount of TGF-beta 1 mRNA in glomeruli of the Hi-salt rats, compared with the Lo-salt rats (0.63 ± 0.04 vs. 0.33 ± 0.03; P = 0.0008).

Production of total (latent plus active), as well as active, TGF-beta 1 was examined in glomerular and cortical tubular cell preparations from rats on the 8.0% NaCl and 0.3% NaCl diets (n = 4 animals in each group). Secretion of total TGF-beta 1 was increased (P < 0.05) in both preparations obtained from animals on the 8.0% NaCl diet, but secretion of active TGF-beta 1 was increased only in glomeruli from the Hi-salt group (Fig. 4). To determine whether potassium channels were involved in TGF-beta production, we followed the protocol of Ohno and associates (34), who used TEA and glybenclamide to examine TGF-beta 1 production in endothelial cells in culture. Addition of TEA to the medium reduced active and total TGF-beta 1 to levels comparable to those produced by glomeruli obtained from the Lo-salt group (Fig. 4); TEA had no effect on TGF-beta 1 production by tubular cells. Glybenclamide had no effect on TGF-beta 1 production by either preparation. Total TGF-beta 1 production by cardiac tissue from the Hi-salt group was greater (760 ± 46 vs. 563 ± 91 fg · h-1 · mg protein-1; P < 0.05) than that secreted by cardiac tissue from the Lo-salt group. TEA did not alter production of TGF-beta 1 by cardiac tissue from the Hi-salt or Lo-salt groups (Hi-salt, 760 ± 46 vs. 689 ± 37; Lo-salt, 563 ± 91 vs. 650 ± 75 fg · h-1 · mg protein-1).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 4.   A: production of total (latent plus active) TGF-beta 1 by glomeruli and tubules was greater from animals receiving 8.0% NaCl diet for 4 days, compared with those samples from the corresponding Lo-salt group. B: active TGF-beta 1 was greater only from glomeruli from the Hi-salt group. Augmented production was abrogated by addition of tetraethylammonium (TEA) in the Hi-salt group, but was not affected by glybenclamide. * P < 0.05 compared with corresponding Lo-salt group. ddager  P < 0.05 compared with baseline values of the Hi-salt group.

    DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

TGF-beta s are multifunctional growth factors that play an important role in kidney growth, development, and senescence (2, 9, 10, 24, 33, 39, 41, 48, 50-52). Expressions of TGF-beta 1, -beta 2, and -beta 3 have been identified in both glomeruli and tubules (6, 7, 39, 40, 51, 53, 54). A majority of studies have focused on expression of these growth factors in developmental and pathological states in the kidney, but recent evidence supports a functional role of TGF-beta in adult animals, including tubular cell hypertrophy and proliferation, stimulation of adenylyl cyclase, and inhibition of cathepsin production (4, 5, 30, 40). In the current studies, we examined the potential role of dietary salt in modifying growth factor expression in the kidney. Physiological adaptation of TGF-beta expression to dietary salt has not been examined but is an important consideration, particularly in pathological states that produce glomerulosclerosis. Our current findings showed that an increase in dietary salt produced sustained increases in steady-state levels of mRNA of TGF-beta 1, -beta 2, and -beta 3 in the kidney, compared with rats that received a diet that was identical in composition except for the lower content of sodium chloride. While serum concentrations of TGF-beta 1 did not change, the 8.0% NaCl diet increased urinary excretion of TGF-beta 1. Thus the kidney was the source of augmented excretion of TGF-beta 1. Diuretics (furosemide or chlorothiazide), which were added to the 8.0% NaCl diets in part to determine whether increasing urinary flow rates modulated TGF-beta , did not further augment synthesis of TGF-beta 1. Production of TGF-beta 1 increased in both glomeruli and tubules, although the active form of TGF-beta 1 was secreted in greater amounts only from glomeruli. Enhanced glomerular production of both inactive and active TGF-beta 1 induced by the 8.0% NaCl diet was inhibited by addition of TEA and not glybenclamide. Dietary salt therefore appeared to activate a TEA-sensitive potassium channel that in turn increased glomerular production of TGF-beta 1.

As reviewed in detail by Davies (17), blood coursing through a vessel produces shear stress, a frictional force that directly alters endothelial cell function. An early event in this process is opening of a shear-activated potassium channel (36), which hyperpolarizes the endothelium and increases cytoplasmic calcium (16, 32, 45). Ohno and associates (34) demonstrated shear-induced expression of TGF-beta 1 in endothelial cells in culture. Blockade of the shear-activated potassium channel with TEA, 3 mM, but not glybenclamide, 10-5 M, produced dramatic reductions in gene transcription and protein activity of TGF-beta 1 (34). Our current studies showed this effect occurs in vivo, specifically in glomeruli and not in tubular cells or in the heart. We propose that an increase in dietary salt, by increasing blood volume (18), produced shear stress in glomeruli and increased expression of TGF-beta 1 specifically in that region of the nephron. Augmented expression of TGF-beta 1 in the tubules and heart was modest and occurred by a different mechanism that was not defined in this study. We suggest that because active TGF-beta 1, but not the latent form, is a low-molecular-weight protein, significant amounts of the active form can appear in glomerular ultrafiltrate and subsequently interact with proximal tubular cells to promote cell growth and hypertrophy (5, 22, 30, 40) and stimulate autocrine production of TGF-beta , which has been demonstrated to occur in cells in culture (1, 26).

In conclusion, to the extent that our work can be applied in vivo, although angiotensin II stimulates renal production of TGF-beta (3, 25, 49), dietary salt increases TGF-beta not through the renin-angiotensin system but instead by a mechanism that involves alteration of shear stress in glomeruli and activation of a TEA-sensitive potassium channel. The role(s) of this growth factor in the renal adaptation to dietary salt is uncertain, although TGF-beta may alter NO production, which in turn modulates glomerular hemodynamics, glomerular filtration rate, and renin secretion (23, 31, 46). Finally, a pathogenic role of TGF-beta in glomerulosclerosis has been described (2, 21, 24, 29, 50, 51, 54). One recent report showed increased expression of TGF-beta in isolated glomeruli from Dahl salt-sensitive rats that had been made hypertensive by a 4-wk treatment with an 8.0% NaCl diet. These animals demonstrated marked nephrosclerosis (47). Although a time course was not performed and control animals that maintained a normal blood pressure and did not manifest nephrosclerosis on the 8.0% NaCl diet were not examined in that study, by directly modifying TGF-beta expression in glomeruli, the role dietary salt may play in facilitating glomerulosclerosis through a shear stress-related mechanism should be entertained.

    ACKNOWLEDGEMENTS

We thank Dr. Thomas S. Winokur, University of Alabama at Birmingham, for helpful discussions, and the Media Service of the Birmingham Veterans Affairs Medical Center, for the photography.

    FOOTNOTES

This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-46199 and by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs.

Address for reprint requests: P. W. Sanders, Division of Nephrology/Dept. of Medicine, 642 Lyons-Harrison Research Bldg., Univ. of Alabama at Birmingham, Birmingham, AL 35294-0007.

Received 18 August 1997; accepted in final form 19 November 1997.

    REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

1.   Agrotis, A., J. Saltis, and A. Bobik. Transforming growth factor-beta 1 gene activation and growth of smooth muscle from hypertensive rats. Hypertension 23: 593-599, 1994[Abstract/Free Full Text].

2.   Akagi, Y., Y. Isaka, M. Arai, T. Kaneko, M. Takenaka, T. Moriyama, Y. Kaneda, A. Ando, Y. Orita, T. Kamada, N. Ueda, and E. Imai. Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int. 50: 148-155, 1996[Medline].

3.   Anderson, P. W., X. Y. Zhang, J. Tian, J. D. Correale, X. P. Xi, D. Yang, K. Graf, R. E. Law, and W. A. Hsueh. Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. Kidney Int. 50: 745-753, 1996[Medline].

4.   Anderson, R. J., H. T. Sponsel, R. Breckon, T. Marcell, and J. P. Hoeffler. Transforming growth factor-beta 1 regulation of signal transduction in two renal epithelial cell lines. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F584-F591, 1993[Abstract/Free Full Text].

5.   Anderson, R. J., H. T. Sponsel, D. J. Kroll, S. Jackson, R. Breckon, and J. P. Hoeffler. Escape from the antiproliferative effect of transforming growth factor-beta 1 in LLC-PK1 renal epithelial cells. Kidney Int. 45: 642-649, 1994[Medline].

6.   Ando, T., S. Okuda, K. Tamaki, K. Yoshitomi, and M. Fujishima. Localization of transforming growth factor-beta and latent transforming growth factor-beta binding protein in rat kidney. Kidney Int. 47: 733-739, 1995[Medline].

7.   Anzano, M. A., A. B. Roberts, C. A. Meyers, A. Komoriya, L. C. Lamb, J. M. Smith, and M. B. Sporn. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res. 42: 4776-4778, 1982[Abstract/Free Full Text].

8.   Blanchette, F., R. Day, W. Dong, M.-H. Laprise, and C. M. Dubois. TGFbeta 1 regulates gene expression of its own converting enzyme furin. J. Clin. Invest. 99: 1974-1983, 1997[Medline].

9.   Border, W. A., N. A. Noble, T. Yamamoto, J. R. Harper, Y. Yamaguchi, M. D. Pierschbacher, and E. Ruoslahti. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361-364, 1992[Medline].

10.   Border, W. A., S. Okuda, L. R. Languino, M. B. Sporn, and E. Ruoslahti. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346: 371-374, 1990[Medline].

11.   Cattell, V., T. Cook, and S. Moncada. Glomeruli synthesize nitrite in experimental nephrotoxic nephritis. Kidney Int. 38: 1056-1060, 1990[Medline].

12.   Chen, G., and D. W. Cheung. Characterization of acetylcholine-induced membrane hyperpolarization in endothelial cells. Circ. Res. 70: 257-263, 1992[Abstract/Free Full Text].

13.   Chen, P. Y., and P. W. Sanders. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 88: 1559-1567, 1991.

14.   Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987[Medline].

15.   Cook, N. S. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol. Sci. 9: 21-28, 1988[Medline].

16.   Cooke, J. P., E. Rossitch, Jr., N. A. Andon, J. Loscalzo, and V. J. Dzau. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J. Clin. Invest. 88: 1663-1671, 1991.

17.   Davies, P. F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75: 519-560, 1995[Abstract/Free Full Text].

18.   Davis, J. M., D. A. Häberle, and T. Kawata. The control of glomerular filtration rate and renal blood flow in chronically volume-expanded rats. J. Physiol. (Lond.) 402: 473-495, 1988[Abstract/Free Full Text].

19.   Flanders, K. C., T. S. Winokur, M. G. Holder, and M. B. Sporn. Hyperthermia induces expression of transforming growth factor-beta s in rat cardiac cells in vitro and in vivo. J. Clin. Invest. 92: 404-410, 1993.

20.   Gibbons, G. H., R. E. Pratt, and V. J. Dzau. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J. Clin. Invest. 90: 456-461, 1992.

21.   Herrera, G. A., J. J. Shultz, S.-j. Soong, and P. W. Sanders. Growth factors in monoclonal light chain-related renal diseases. Hum. Pathol. 25: 883-892, 1994[Medline].

22.   Humes, H. D., T. F. Beales, D. A. Cieslinski, I. O. Sanchez, and T. P. Page. Effects of transforming growth factor-beta , transforming growth factor-alpha , and other growth factors on renal proximal tubule cells. Lab. Invest. 64: 538-545, 1991[Medline].

23.   Ikenaga, H., H. Suzuki, N. Ishii, H. Itoh, and T. Saruta. Role of NO on pressure-natriuresis in Wistar-Kyoto and spontaneously hypertensive rats. Kidney Int. 43: 205-211, 1993[Medline].

24.   Isaka, Y., Y. Fujiwara, N. Ueda, Y. Kaneda, T. Kamada, and E. Imai. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 92: 2597-2601, 1993.

25.   Kagami, S., W. A. Border, D. E. Miller, and N. A. Noble. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J. Clin. Invest. 93: 2431-2437, 1994.

26.   Kaname, S., S. Uchida, E. Ogata, and K. Kurokawa. Autocrine secretion of transforming growth factor-beta in cultured rat mesangial cells. Kidney Int. 42: 1319-1327, 1992[Medline].

27.   Kitamura, M., T. Sütö, T. Yokoo, F. Shimizu, and L. G. Fine. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J. Immunol. 156: 2964-2971, 1996[Abstract].

28.   Koibuchi, Y., W. S. Lee, G. H. Gibbons, and R. E. Pratt. Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II. Hypertension 21: 1046-1050, 1993[Abstract/Free Full Text].

29.   Lee, L. K., T. W. Meyer, A. S. Pollock, and D. H. Lovett. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J. Clin. Invest. 96: 953-964, 1995.

30.   Ling, H., S. Vamvakas, G. Busch, J. Dämmrich, L. Schramm, F. Lang, and A. Heidland. Suppressing role of transforming growth factor-beta 1 on cathepsin activity in cultured kidney tubule cells. Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F911-F917, 1995[Abstract/Free Full Text].

31.   Majid, D. S. A., A. Williams, P. J. Kadowitz, and L. G. Navar. Renal responses to intra-arterial administration of nitric oxide donor in dogs. Hypertension 22: 535-541, 1993[Abstract/Free Full Text].

32.   Mo, M., S. G. Eskin, and W. P. Schilling. Flow-induced changes in Ca2+ signaling of vascular endothelial cells: effect of shear stress and ATP. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H1698-H1707, 1991[Abstract/Free Full Text].

33.   Nakamura, T., D. Miller, E. Ruoslahti, and W. A. Border. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int. 41: 1213-1221, 1992[Medline].

34.   Ohno, M., J. P. Cooke, V. J. Dzau, and G. H. Gibbons. Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. J. Clin. Invest. 95: 1363-1369, 1995.

35.   Ohno, M., G. H. Gibbons, V. J. Dzau, and J. P. Cooke. Shear stress elevates endothelial cGMP: role of a potassium channel and G protein coupling. Circulation 88: 193-197, 1993[Abstract/Free Full Text].

36.   Olesen, S.-P., D. E. Clapham, and P. F. Davies. Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 331: 168-170, 1988[Medline].

37.   Roberts, A. B., M. A. Anzano, L. M. Wakefield, N. S. Roche, D. F. Stern, and M. B. Sporn. Type beta  transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82: 119-123, 1985[Abstract/Free Full Text].

38.   Roberts, A. B., L. C. Lamb, D. L. Newton, M. B. Sporn, J. E. De Larco, and G. J. Todaro. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc. Natl. Acad. Sci. USA 77: 3494-3498, 1980[Abstract/Free Full Text].

39.   Roberts, A. B., and M. B. Sporn. Transforming growth factor beta . Adv. Cancer Res. 51: 107-145, 1988[Medline].

40.   Rocco, M. V., Y. Chen, S. Goldfarb, and F. N. Ziyadeh. Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int. 41: 107-114, 1992[Medline].

41.   Rogers, S. A., G. Ryan, A. F. Purchio, and M. R. Hammerman. Metanephric transforming growth factor-beta 1 regulates nephrogenesis in vitro. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F996-F1002, 1993[Abstract/Free Full Text].

42.   Schultz-Cherry, S., H. Chen, D. F. Mosher, T. M. Misenheimer, H. C. Krutzsch, D. D. Roberts, and J. E. Murphy-Ullrich. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J. Biol. Chem. 270: 7304-7310, 1995[Abstract/Free Full Text].

43.   Schultz-Cherry, S., J. Lawler, and J. E. Murphy-Ullrich. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J. Biol. Chem. 269: 26783-26788, 1994[Abstract/Free Full Text].

44.   Schultz-Cherry, S., S. Ribeiro, L. Gentry, and J. E. Murphy-Ullrich. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J. Biol. Chem. 269: 26775-26782, 1994[Abstract/Free Full Text].

45.   Shen, J., F. W. Luscinskas, A. Connolly, C. F. Dewey, Jr., and M. A. Gimbrone, Jr. Fluid shear stress modulates cytosolic free calcium in vascular endothelial cells. Am. J. Physiol. 262 (Cell Physiol. 31): C384-C390, 1992[Abstract/Free Full Text].

46.   Singh, I., M. Grams, W.-H. Wang, T. Yang, P. Killen, A. Smart, J. Schnermann, and J. P. Briggs. Coordinate regulation of renal expression of nitric oxide synthase, renin, and angiotensinogen mRNA by dietary salt. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F1027-F1037, 1996[Abstract/Free Full Text].

47.   Tamaki, K., S. Okuda, M. Nakayama, T. Yanagida, and M. Fujishima. Transforming growth factor-beta 1 in hypertensive renal injury in Dahl salt-sensitive rats. J. Am. Soc. Nephrol. 7: 2578-2589, 1996[Abstract].

48.   Tomooka, S., W. A. Border, B. C. Marshall, and N. A. Noble. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int. 42: 1462-1469, 1992[Medline].

49.   Van Det, N. F., J. T. Tamsma, J. van den Born, N. A. Verhagen, L. P. van den Heuvel, C. W. Lowik, J. H. Berden, J. A. Bruijn, M. R. Daha, and F. J. van der Woude. Differential effects of angiotensin II and transforming growth factor beta on the production of heparan sulfate proteoglycan by mesangial cells in vitro. J. Am. Soc. Nephrol. 7: 1015-1023, 1996[Abstract].

50.   Yamamoto, T., T. Nakamura, N. A. Noble, E. Ruoslahti, and W. A. Border. Expression of transforming growth factor beta  is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. USA 90: 1814-1818, 1993[Abstract/Free Full Text].

51.   Yamamoto, T., N. A. Noble, A. H. Cohen, C. C. Nast, A. Hishida, L. I. Gold, and W. A. Border. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int. 49: 461-469, 1996[Medline].

52.   Yamamoto, T., N. A. Noble, D. E. Miller, and W. A. Border. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int. 45: 916-927, 1994[Medline].

53.   Yoshioka, K., T. Takemura, K. Murakami, M. Okada, S. Hino, H. Miyamoto, and S. Maki. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab. Invest. 68: 154-163, 1993[Medline].

54.   Zhu, L., G. A. Herrera, J. E. Murphy-Ullrich, Z.-Q. Huang, and P. W. Sanders. Pathogenesis of glomerulosclerosis in light chain deposition disease: role for transforming growth factor-beta . Am. J. Pathol. 147: 375-385, 1995[Abstract].


AJP Renal Physiol 274(4):F635-F641



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
W.-Z. Ying, K. Aaron, and P. W. Sanders
Mechanism of dietary salt-mediated increase in intravascular production of TGF-{beta}1
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F406 - F414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. R. Spurgeon-Pechman, D. L. Donohoe, D. L. Mattson, H. Lund, L. James, and D. P. Basile
Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F269 - F278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W.-Z. Ying and P. W. Sanders
Enhanced expression of EGF receptor in a model of salt-sensitive hypertension
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F314 - F321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P.-X. Wang and P. W. Sanders
Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: a primary disorder of vascular smooth muscle
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F236 - F242.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W.-Z. Ying and P. W. Sanders
The interrelationship between TGF-{beta}1 and nitric oxide is altered in salt-sensitive hypertension
Am J Physiol Renal Physiol, November 1, 2003; 285(5): F902 - F908.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. J. Dahly, K. M. Hoagland, A. K. Flasch, S. Jha, S. R. Ledbetter, and R. J. Roman
Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R757 - R767.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. F. Husted, R. D. Sigmund, and J. B. Stokes
Mechanisms of inactivation of the action of aldosterone on collecting duct by TGF-beta
Am J Physiol Renal Physiol, March 1, 2000; 278(3): F425 - F433.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W.-Z. Ying and P. W. Sanders
Dietary salt increases endothelial nitric oxide synthase and TGF-beta 1 in rat aortic endothelium
Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1293 - H1298.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W.-Z. Ying and P. W. Sanders
Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-beta 1
Am J Physiol Renal Physiol, July 1, 1998; 275(1): F18 - F24.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W.-Z. Ying, H. Xia, and P. W. Sanders
Nitric Oxide Synthase (NOS2) Mutation in Dahl/Rapp Rats Decreases Enzyme Stability
Circ. Res., August 17, 2001; 89(4): 317 - 322.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ying, W.-Z.
Right arrow Articles by Sanders, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ying, W.-Z.
Right arrow Articles by Sanders, P. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE